Expression of natural antimicrobials by human placenta and fetal membranes

A E King1, A Paltoo, R W Kelly

  • 1Department of Physiology, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8. anne.king@utoronto.ca

Placenta
|March 4, 2006
PubMed

Insights

Infection-associated preterm birth may involve changes in natural antimicrobial molecules like beta-defensins (HBD) and elafin. These molecules are present in placental tissues and their expression can be influenced by inflammatory cytokines.

Area of Science:

  • Reproductive biology
  • Immunology
  • Obstetrics

Background:

  • Infection-associated preterm birth is a significant clinical challenge.
  • Natural antimicrobial molecules, such as beta-defensins (HBD) and elafin, play a role in host defense.
  • Their role in the context of pregnancy and preterm birth requires further investigation.

Purpose of the Study:

  • To investigate the expression and regulation of HBD and elafin in placental tissues.
  • To determine if expression levels differ in term pregnancy, labor, or in response to inflammatory stimuli.

Main Methods:

  • Immunohistochemistry was used to localize HBD1-3 and elafin in placental and fetal membrane tissues.
  • Real-time quantitative PCR analyzed mRNA expression in primary trophoblast cells stimulated with IL-1beta.
  • Tissues were examined from women in term pregnancy, with and without active labor.

Main Results:

  • HBD1-3 and elafin were localized to trophoblast layers of the placenta and fetal membranes, as well as amnion epithelium and decidua.
  • No significant differences in expression were observed between non-laboring and actively laboring term pregnancy samples.
  • In vitro, IL-1beta upregulated HBD2 and elafin mRNA expression in primary trophoblast cells.

Conclusions:

  • The chorion and placental trophoblast layers act as crucial barriers against uterine infections.
  • Expression of natural antimicrobials may be modulated by inflammatory mediators during labor or infection.
  • Altered antimicrobial expression could represent an adaptive response to enhance uterine protection during periods of increased susceptibility to infection.

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...